Inaugural Conference on Implementation Science for Cancer Control in Africa (ISC2-Africa)

非洲癌症控制实施科学首届会议(ISC2-非洲)

基本信息

  • 批准号:
    10318327
  • 负责人:
  • 金额:
    $ 1.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-08 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY According to the World Health Organization, morbidity and mortality from non-communicable diseases in Africa will surpass that of communicable diseases by 2030. While Africa faces several challenges in controlling cancer, the field of Implementation Science (IS) offers a ray of hope for cancer control in Africa. Defined as the “study of methods to promote the adoption and integration of evidence-based practices, interventions, and policies into routine health care and public health settings to improve the impact on population health”, IS is crucial to address the disproportionate burden of cancer in Africa. Unfortunately, Africa does not have the much needed research workforce for IS. The African Organization for Research and Training in Cancer (AORTIC), African Behavioral Research (ABeR) Center, Africa Cancer ECHO, and International Cancer Research Partnership (ICRP) have partnered to create an Implementation Science for Cancer Control in Africa (ISC2- Africa) Network. We are proposing an ISC2-Africa inaugural conference to be held biennially as a pre- conference to the AORTIC International Cancer Conference. The primary goal of the ISC2-Africa conference is to elevate IS scholarship in Africa. In addition, we will develop an African IS workforce that will bring unique perspective to addressing cancer control in Africa as well as effectively deliver and integrate cancer control interventions within the Africa health care systems and communities. Utilizing an innovative framework, the conference will foster: (1) the mobilization of resources within African countries for Afro-centric IS strategies; (2) partnership with key stakeholders for effective and culturally appropriate IS research; and (3) the development and successful implementation of IS research across Africa. A cornerstone of our conference -- and we believe the most innovative aspect-- is that the final conference agenda is based on the needs identified by cancer scientists and clinicians in Africa through a SWOT Analysis survey.
项目摘要 根据世界卫生组织,非洲非传染性疾病的发病率和死亡率 到2030年将超过传染病。虽然非洲在控制癌症方面面临着若干挑战, 实施科学(IS)领域为非洲的癌症控制提供了一线希望。定义为“研究 促进采用和整合循证实践、干预措施和政策的方法, 常规卫生保健和公共卫生环境,以改善对人口健康的影响”,是至关重要的解决 癌症在非洲的不成比例的负担。不幸的是,非洲没有急需的研究, 劳动力为。非洲癌症研究和培训组织(AORTIC) 行为研究(ABeR)中心,非洲癌症ECHO和国际癌症研究 国际辐射防护委员会(ICRP)合作创建了非洲癌症控制实施科学(ISC 2)。 非洲)网络。我们建议每两年举行一次国际科学委员会第二届会议-非洲开幕会议, AORTIC国际癌症会议。ISC 2-非洲会议的主要目标是 提升非洲的IS奖学金。此外,我们还将培养一支非洲信息系统工作队伍, 非洲癌症控制以及有效提供和综合癌症控制的前景 非洲卫生保健系统和社区内的干预措施。利用创新的框架, 会议将促进:(1)在非洲国家内部为以非洲为中心的信息系统战略调动资源;(2) 与主要利益相关者建立伙伴关系,开展有效的和文化上适当的信息系统研究;(3)发展 并在非洲成功开展基础设施服务研究。我们会议的基石--我们相信 最具创新性的方面是,最终的会议议程是基于癌症所确定的需求, 科学家和临床医生在非洲通过SWOT分析调查。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FOLAKEMI T ODEDINA其他文献

FOLAKEMI T ODEDINA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FOLAKEMI T ODEDINA', 18)}}的其他基金

Florida Cancer ReTOOL Program for Underrepresented Minority Students
针对代表性不足的少数族裔学生的佛罗里达癌症 ReTOOL 计划
  • 批准号:
    10251054
  • 财政年份:
    2021
  • 资助金额:
    $ 1.5万
  • 项目类别:
Florida Cancer ReTOOL Program for Underrepresented Minority Students
针对代表性不足的少数族裔学生的佛罗里达癌症 ReTOOL 计划
  • 批准号:
    10416662
  • 财政年份:
    2021
  • 资助金额:
    $ 1.5万
  • 项目类别:
The 6th Biennial Science of Global Prostate Cancer Disparities in Black Men of Africa
第六届全球前列腺癌非洲黑人差异科学双年展
  • 批准号:
    10404175
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
Investigations of Black Ancestry on Pancreatic Cancer Tumor Biology for US-related Cancer Health Disparities
黑人血统对胰腺癌肿瘤生物学与美国相关癌症健康差异的调查
  • 批准号:
    10166025
  • 财政年份:
    2018
  • 资助金额:
    $ 1.5万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10006211
  • 财政年份:
    2018
  • 资助金额:
    $ 1.5万
  • 项目类别:
OUTREACH CORE
外展核心
  • 批准号:
    10477311
  • 财政年份:
    2018
  • 资助金额:
    $ 1.5万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10241337
  • 财政年份:
    2018
  • 资助金额:
    $ 1.5万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10477300
  • 财政年份:
    2018
  • 资助金额:
    $ 1.5万
  • 项目类别:
OUTREACH CORE
外展核心
  • 批准号:
    10006219
  • 财政年份:
    2018
  • 资助金额:
    $ 1.5万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10268881
  • 财政年份:
    2018
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了